ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2309건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 62 | Completed | TXA127 for the Treatment of Severe COVID-19 | COVID-19 | Drug: TXA127 Drug: Placebo |
Phase 2 | Columbia University, Constant Therapeutics LLC | OTHER | 22 | All | 18 Years | Columbia University Irving Medical Center, New York, New York, United States |
| 61 | Recruiting | UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients | COVID-19 Pneumonia | Biological: umbilical cord mesenchymal stem cells Drug: paxlovid |
Phase 3 | Shanghai East Hospital | OTHER | 60 | All | 18 Years ~ 75 Years | Shanghai East Hospital, Shanghai Tongji University, Shanghai, Shanghai, China |
| 60 | Recruiting | UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients With Refractory Hypoxia | COVID-19 Pneumonia | Biological: UC-MSCs treatment | Phase 3 | Shanghai East Hospital, Sir Run Run Shaw Hospital | OTHER | 60 | All | 18 Years ~ 85 Years | Shanghai East Hospital, Shanghai Tongji University, Shanghai, Shanghai, China |
| 59 | Withdrawn | Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients | COVID-19 | Drug: Ulinastatin Drug: Placebo |
Phase 2 | Stanford University | OTHER | 0 | All | 18 Years | Stanford University, Stanford, California, United States |
| 58 | Terminated | Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19 | COVID-19 | Drug: FSD201 Drug: Placebo Other: Standard of Care for Covid-19 |
Phase 2 | FSD Pharma, Inc. | INDUSTRY | 53 | All | 18 Years | Miami, Florida, Miami, Florida, United States Palms of Pasadena Hospital, Saint Petersburg, Florida, Saint Petersburg, Florida, United States Theia Clinical Research, St. Petersburg, Florida, Saint Petersburg, Florida, United States Idaho Falls, Idaho, Idaho Falls, Idaho, United States Winfield, Illinois, Winfield, Illinois, United States Butte, Montana, Butte, Montana, United States Tulsa, Oklahoma, Tulsa, Oklahoma, United States Kingsport, Tennessee, Kingsport, Tennessee, United States Amarillo, Texas, Amarillo, Texas, United States Mesquite, Texas, Mesquite, Texas, United States |
| 57 | Completed | Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS | Coronavirus | Biological: Umbilical Cord Lining Stem Cells (ULSC) Other: Placebo (carrier control) |
Phase 2 | Restem, LLC. | INDUSTRY | 17 | All | 18 Years | Miami Baptist Hospital, Miami, Florida, United States Sanford Research, Sioux Falls, South Dakota, United States |
| 56 | Withdrawn | Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19 | Corona Virus Infection | Biological: UCMSCs Other: Placebo |
Phase 1 | Joshua M Hare | OTHER | 0 | All | 18 Years |
